---
title: Metrum News | Kyle Baron
---

[![Metrum research group](https://news.metrumrg.com/hs-fs/hubfs/Metrum%20-April2017/images/logo.png?width=235&height=55&name=logo.png "logo.png")](https://www.metrumrg.com/) [![](https://news.metrumrg.com/hs-fs/hubfs/Metrum%20-April2017/images/footer-logo%20(1).png?width=137&height=33&name=footer-logo%20(1).png "logo.png")](https://www.metrumrg.com/)

[Contact](https://info.metrumrg.com/contact) <https://news.metrumrg.com/blog/author/kyle-baron#search>

- [About](https://www.metrumrg.com/about/)
- [Services](https://www.metrumrg.com/services/)
- [Metworx](https://www.metrumrg.com/solution/metworx/)
- [Open Science](https://www.metrumrg.com/open-science/)
- [Publications](https://www.metrumrg.com/publications/)
- [Blog](https://news.metrumrg.com/blog)
- [Events](https://www.metrumrg.com/events/)
- [Careers](https://www.metrumrg.com/careers/)

- [About](https://www.metrumrg.com/about/)
- [Services](https://www.metrumrg.com/services/)
- [Metworx](https://www.metrumrg.com/solution/metworx/)
- [Open Science](https://www.metrumrg.com/open-science/)
- [Publications](https://www.metrumrg.com/publications/)
- [Blog](https://news.metrumrg.com/blog)
- [Events](https://www.metrumrg.com/events/)
- [Careers](https://www.metrumrg.com/careers/)

Enter Search Item

Enter Search Item

# News

## Kyle Baron

### Recent Posts

## [Hepatitis C Viral Dynamic Modeling and Clinical Pharmacology](https://news.metrumrg.com/blog/hepatitis-c-viral-dynamic-modeling-and-clinical-pharmacology)

 Posted by [Kyle Baron](https://news.metrumrg.com/blog/author/kyle-baron) on May 31, 2017, 3:51:56 PM

- [Tweet](https://twitter.com/share)

An article in the recent issue of Heptaology illustrates an insightful application of hepatitis C viral dynamic modeling and clinical pharmacology. Guedj et al. (Hepatology 2012 55: 1030-1037) present an HCV dynamic model of viral load versus time during mericitabine therapy. Rather than seeing the clear bi-phasic viral load profile we see with interferon and the protease inhibitors (with characteristic sharp initial drop in viral load), the viral load decline during mericitabine therapy is more complicated: either a slower bi-phasic profile or mono-phasic profile. The authors propose an interesting modeling solution to gain insight into mericitabine’s antiviral activity.

[Read More](https://news.metrumrg.com/blog/hepatitis-c-viral-dynamic-modeling-and-clinical-pharmacology)

 0 Comments [Click here to read/write comments](https://news.metrumrg.com/blog/hepatitis-c-viral-dynamic-modeling-and-clinical-pharmacology#comments-listing)

 Topics: [Infectious Diseases](https://news.metrumrg.com/blog/topic/infectious-diseases)

[All posts](https://news.metrumrg.com/blog/all)

## We love to share!

Please take advantage of the content we provide here. Our goal is to help, encourge, and inspire you in your own work! If you have suggestions for blog topics, or would like to co-author a blog post with us, [let us know](https://info.metrumrg.com/contact)!

### Posts by Topic

- [Metrum News (38)](https://news.metrumrg.com/blog/topic/metrum-news)
- [Employee Spotlight (14)](https://news.metrumrg.com/blog/topic/employee-spotlight)
- [Methodology, Tools, and Computation (13)](https://news.metrumrg.com/blog/topic/methodology-tools-and-computation)
- [Community Outreach (11)](https://news.metrumrg.com/blog/topic/community-outreach)
- [Open Science (11)](https://news.metrumrg.com/blog/topic/open-science)
- [Neurodegenerative Diseases (3)](https://news.metrumrg.com/blog/topic/neurodegenerative-diseases)
- [Confidence Intervals (2)](https://news.metrumrg.com/blog/topic/confidence-intervals)
- [Oncology (2)](https://news.metrumrg.com/blog/topic/oncology)
- [P-values (2)](https://news.metrumrg.com/blog/topic/p-values)
- [Scientific Writing (2)](https://news.metrumrg.com/blog/topic/scientific-writing)
- [Significance (2)](https://news.metrumrg.com/blog/topic/significance)
- [AI (1)](https://news.metrumrg.com/blog/topic/ai)
- [Alzheimer's (1)](https://news.metrumrg.com/blog/topic/alzheimers)
- [Bayesian (1)](https://news.metrumrg.com/blog/topic/bayesian)
- [Bone Health (1)](https://news.metrumrg.com/blog/topic/bone-health)
- [Breast Cancer (1)](https://news.metrumrg.com/blog/topic/breast-cancer)
- [CEO (1)](https://news.metrumrg.com/blog/topic/ceo)
- [Infectious Diseases (1)](https://news.metrumrg.com/blog/topic/infectious-diseases)
- [Machine Learning (1)](https://news.metrumrg.com/blog/topic/machine-learning)
- [Mental Health (1)](https://news.metrumrg.com/blog/topic/mental-health)
- [Other (1)](https://news.metrumrg.com/blog/topic/other)
- [Pediatrics (1)](https://news.metrumrg.com/blog/topic/pediatrics)
- [Rare Disorders (1)](https://news.metrumrg.com/blog/topic/rare-disorders)
- [Service (1)](https://news.metrumrg.com/blog/topic/service)
- [Statistics (1)](https://news.metrumrg.com/blog/topic/statistics)
- [Women's Health (1)](https://news.metrumrg.com/blog/topic/womens-health)

see all

### Subscribe to Email Updates

### Recent Posts

[![Metrum research group ](https://news.metrumrg.com/hs-fs/hubfs/Metrum%20-April2017/images/footer-logo.png?width=145&height=35&name=footer-logo.png "footer-logo.png")](https://www.metrumrg.com/)

[Privacy](https://www.metrumrg.com/privacy-policy/)  |  2020 Metrum Research Group

<https://twitter.com/MetrumRG> <https://www.linkedin.com/company/metrum-research-group>